CQ Medical’s Iris AirShuttle™ Patient Transfer Platform Recognized at Women in Innovation Award Showcase
AVONDALE, Pa., March 5, 2025 /PRNewswire/ -- The Iris AirShuttle™, a patient transfer platform developed by CQ Medical, is designed to streamline the transfer of patients from procedures to imaging. Recently, it was featured at the Women in Innovation Award Showcase, an event that celebrated Professor Iris Grunwald from the University of Dundee, UK, along with her team at the...
BTL’s EMFACE Surpasses 1 Million Treatments, Becoming the Fastest-Growing Non-Invasive Facial Lifting Procedure
PRAGUE, March 5, 2025 /PRNewswire/ -- EMFACE, the revolutionary non-invasive facial treatment, has reached an extraordinary milestone—becoming the fastest procedure of its kind to surpass 1 million treatments worldwide in just under two years. This achievement cements EMFACE as the leading non-invasive facial procedure uniquely designed to treat both the skin and underlying muscles for a more youthful, lifted appearance....
Bioheng Therapeutics Announces FDA Clearance of IND Application for CD7 UCAR T Cell Therapy in T-ALL/LBL
BOSTON, March 5, 2025 /PRNewswire/ -- Bioheng Therapeutics US LLC ("Bioheng"), a clinical-stage biotech company dedicated to developing innovative universal CAR-T cell therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for CTD402, a CD7-targeted universal CAR-T (UCAR-T) cell therapy, for the treatment of pediatric and adult patients with relapsed/refractory...
Business Plan Contest “Photonics Challenge 2025” was Successfully Held in Hamamatsu City, the Center of the Optical Industry
Three companies with outstanding optical technology – Beyond Optical Medical Technologies, Ectobrain Devices and Catana Corporation – presented groundbreaking ideas and are awarded for their business plans HAMAMATSU, Japan, March 5, 2025 /PRNewswire/ -- The Central Japan Startup Ecosystem Consortium is pleased to announce that Photonics Challenge 2025, a business contest that supports the expansion of optical technology applications by startups and small and...
CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland
CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and large peptide manufacturing facilities across Europe and the US. In Switzerland, CordenPharma will invest >€500m to construct a greenfield site for small to large-scale peptide development and manufacturing located within the Basel region in Muttenz....
XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene’s Commercial Presence in APAC
- XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia. - From the second half of 2024 to now, XPOVIO® was successively approved in Thailand, Malaysia and Indonesia, significantly expanding Antengene's commercial presence in APAC. To date, XPOVIO® has been approved for multiple indications in ten markets across the APAC region. -...
InterSystems Unveils IntelliCare: A Next-Generation, AI-Powered Electronic Health Record
BANGKOK, March 5, 2025 /PRNewswire/ -- InterSystems, a creative data technology provider managing over one billion health records globally, today announced the launch of InterSystems IntelliCare, an AI-powered electronic health record (EHR) and healthcare information system designed to fundamentally change the way clinicians, administrators, and patients engage with healthcare technology. IntelliCare is expected to be effectively...
Pantai Hospital Kuala Lumpur and IMU University Sign MoU to Advance Medical Research and Education
KUALA LUMPUR, Malaysia, March 5, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) and IMU University have officially entered into a five-year Memorandum of Understanding (MoU) to foster collaboration in biomedical science research, training, and knowledge exchange. This partnership marks a significant step in strengthening Malaysia's medical research ecosystem while enhancing educational opportunities for the next generation of healthcare...
GHIT-backed Innovation Achieves Landmark: New Treatment Option for Schistosomiasis Reaches Preschool-Aged Children
TOKYO, March 5, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund is today announcing a significant milestone: the first administration of arpraziquantel to preschool-aged children in Uganda, in an implementation science setting. This new pediatric treatment for schistosomiasis, developed by the GHIT-funded Pediatric Praziquantel Consortium, is being introduced through the Consortium's ADOPT program, which focuses on integrating arpraziquantel...
The Chinese carbon ion center Heyou Hospital selects RayStation
STOCKHOLM, March 4, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that Heyou Hospital, located in Foshan City, Guangdong Province, China, has placed an order for the treatment planning system RayStation®*. Total order value (including service contract) is RMB 51 million (approximately SEK 77 million), of which RMB 18 million (approximately SEK 26 million) will be...
